In addition, the inhibition or depletion of proteins belonging to pathways unrelated to E2:ERα signaling (e.g., metabolic and endocytic proteins) blocks BC cell proliferation, changing the cellular ERα content [11,15,16,17,18,19]. Here, ESR1 is linked to breast cancer.